A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycinFURTH, Alfred F; MANDREKAR, Sumithra J; TAN, Angelina D et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 1, pp 39-45, issn 0344-5704, 7 p.Article

Development and validation of limited sampling models for topotecan lactone pharmacokinetic studies in childrenTURNER, P. Kellie; IACONO, Lisa C; PANETTA, John C et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 4, pp 475-482, issn 0344-5704, 8 p.Article

Evaluation of limited sampling strategies for tacrolimusOP DEN BUIJSCH, Robert A. M; VAN DE PLAS, Afke; STOLK, Leo M. L et al.European journal of clinical pharmacology. 2007, Vol 63, Num 11, pp 1039-1044, issn 0031-6970, 6 p.Article

Validation of the limited-sampling models for carboplatin AUC in combination chemotherapy with taxanesMIYAZAKI, Mitsuru; OGURI, Tetsuya; KURATA, Takayasu et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1911-1914, issn 0250-7005, 4 p.Article

Maximum a posteriori Bayesian estimation of epirubicin clearance by limited samplingRALPH, Lorraine D; THOMSON, Alison H; DOBBS, Nicola A et al.British journal of clinical pharmacology. 2004, Vol 57, Num 6, pp 764-772, issn 0306-5251, 9 p.Article

Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantationLANCERS, P; CREMERS, S. C. L. M; DEN HARTIGH, J et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 5, pp 549-557, issn 0269-2813, 9 p.Article

Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomersNIIOKA, Takenori; MIURA, Masatomo; UNO, Tsukasa et al.European journal of clinical pharmacology. 2008, Vol 64, Num 5, pp 503-509, issn 0031-6970, 7 p.Article

Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studiesMUELLER, Silke C; DREWELOW, Bernd.European journal of clinical pharmacology. 2013, Vol 69, Num 5, pp 1127-1134, issn 0031-6970, 8 p.Article

Proposal of a new limited sampling strategy to predict CYP3A activity using a partial AUC of midazolamKATZENMAIER, Stephanie; MARKERT, Christoph; MIKUS, Gerd et al.European journal of clinical pharmacology. 2010, Vol 66, Num 11, pp 1137-1141, issn 0031-6970, 5 p.Article

A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemiaPIARD, Christine; BRESSOLLE, Francoise; FAKHOURY, May et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 4, pp 609-620, issn 0344-5704, 12 p.Article

Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients : pharmacokinetics and application of limited sampling strategiesZHENG JIAO; ZHONG, Jian-Yong; MING ZHANG et al.European journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 27-37, issn 0031-6970, 11 p.Article

Limited sampling strategies. Authors' replyDAVID, Olivier; JOHNSTON, Atholl; DUMONT, Randall J et al.Clinical pharmacokinetics. 2000, Vol 39, Num 4, pp 311-313, issn 0312-5963Article

Individualized population pharmacokinetic model with limited sampling for cyclosporine monitoring after liver transplantation in clinical practiceLANCERS, P; CREMERS, S. C. L. M; DEN HARTIGHT, J et al.Alimentary pharmacology & therapeutics. 2007, Vol 26, Num 10, pp 1447-1454, issn 0269-2813, 8 p.Article

Analysis of small-scale biological compartments by capillary electrophoresisGOVINDARAJU, K; LLOYD, D. K.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 745, Num 1, pp 127-135, issn 1387-2273Conference Paper

Determining theTime Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling StrategyKATZENMAIER, S; MARKERT, C; RIEDEL, K.-D et al.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 5, pp 666-673, issn 0009-9236, 8 p.Article

Optimal sampling and limited sampling strategies for estimation of unbound platinum AUC after nedaplatin infusionISHIBASHI, Toru; FUKUMURA, Kazuya; YANO, Yoshitaka et al.Anticancer research. 2005, Vol 25, Num 2B, pp 1283-1289, issn 0250-7005, 7 p.Article

Evaluation of a limited sampling method used to determine the bioequivalence of highly variable drugs with long half-livesJACKSON, Andre J.Biopharmaceutics & drug disposition. 2001, Vol 22, Num 5, pp 179-190, issn 0142-2782Article

Beyond cyclosporine : A systematic review of limited sampling strategies for other immunosuppressantsTING, Lillian S. L; VILLENEUVE, Eric; ENSOM, Mary H. H et al.Therapeutic drug monitoring. 2006, Vol 28, Num 3, pp 419-430, issn 0163-4356, 12 p.Article

A Limited Sampling Model to Estimate Exposure to Lenalidomide in Multiple Myeloma PatientsSHIDA, Seiji; TAKAHASHI, Naoto; TAGAWA, Hiroyuki et al.Therapeutic drug monitoring. 2014, Vol 36, Num 4, pp 505-509, issn 0163-4356, 5 p.Article

Training in chorionic villus sampling: Limited experience for US fellowsJENKINS, Thomas M; SCISCIONE, Anthony C; WAPNER, Ronald J et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 4, pp 1288-1290, issn 0002-9378, 3 p.Article

Thirteen Years' Experience of Pharmacokinetic Monitoring and Dosing of Busulfan: Can the Strategy be Improved?BUFFERY, Pamela J; ALLEN, Kirstie M; CHIN, Paul K. L et al.Therapeutic drug monitoring. 2014, Vol 36, Num 1, pp 86-92, issn 0163-4356, 7 p.Article

Limited Sampling Strategies to Predict the Area Under the Concentration―Time Curve for RifampicinMEDELLIN-GARIBAY, Susanna E; CORREA-LOPEZ, Tania; ROMERO-MENDEZ, Carmen et al.Therapeutic drug monitoring. 2014, Vol 36, Num 6, pp 746-751, issn 0163-4356, 6 p.Article

Limited-Sampling Strategies for Therapeutic Drug Monitoring of Moxifloxacin in Patients With TuberculosisPRANGER, Arianna D; KOSTERINK, Jos G. W; VAN ALTENA, Richard et al.Therapeutic drug monitoring. 2011, Vol 33, Num 3, pp 350-354, issn 0163-4356, 5 p.Article

A limited sampling method for the estimation of vigabatrin maximum plasma concentration and area under the curveTAMMARA, V; MAHMOOD, I; YU, D. K et al.Therapeutic drug monitoring. 1997, Vol 19, Num 1, pp 79-82, issn 0163-4356Article

Population pharmacodynamics : strategies for concentration- and effect-controlled clinical trialsEBLING, W. F; LEVY, G.The Annals of pharmacotherapy. 1996, Vol 30, Num 1, pp 12-19, issn 1060-0280Article